How far are we from viral hepatitis elimination service coverage targets?

Diversity of clinical presentation and virological characteristics of hepatitis delta in different regions world-wide: results of the Hepatitis Delta International network

(2017) A. Wranke et al.   JOURNAL OF HEPATOLOGY

Access to medicines: lessons from the HIV response

(2017) Stefano Vella et al.   Lancet HIV

Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India

(2017) Rakesh Aggarwal et al.   PLoS One

A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants

(2016) Hari Shankar et al.   CLINICAL INFECTIOUS DISEASES

Prioritising treatment among people who inject drugs in order to eliminate hepatitis C: addressing reluctance with sound economic analyses

(2016) Yvan J-F Hutin et al.   GUT

Public health and international drug policy

(2016) Joanne Csete et al.   LANCET

Requirements for global elimination of hepatitis B: a modelling study

(2016) Shevanthi Nayagam et al.   LANCET INFECTIOUS DISEASES

Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013

(2016) Louisa Degenhardt et al.   LANCET INFECTIOUS DISEASES

Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990–2014

(2016) Eric Wiesen et al.   VACCINE

Barriers to timely administration of birth dose vaccines in The Gambia, West Africa

(2016) Reiko Miyahara et al.   VACCINE

Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study

(2016) Maud Lemoine et al.   Lancet Global Health

Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia

(2015) Yusuke Shimakawa et al.   GUT

Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China

(2015) Mehlika Toy et al.   PLoS One

Evolution of the Global Use of Unsafe Medical Injections, 2000–2010

(2013) Jacques Pépin et al.   PLoS One

Unnecessary injecting of medicines is still a major public health challenge globally

(2013) C. Gore et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

(2010) Bradley M Mathers et al.   LANCET

Hepatitis B control by 2012 in the WHO Western Pacific Region:

(2009) Manju Rani   BULLETIN OF THE WORLD HEALTH ORGANIZATION

The blood donor in sub-Saharan Africa: a review

(2009) C. T. Tagny et al.   TRANSFUSION MEDICINE